JETi™ Hydrodynamic Thrombectomy System

Peripheral Thrombectomy Device

Single-session treatment of lower extremity venous thrombosis using a novel thrombectomy device

Overview: Retrospective Pilot Study

Khalsa et al., JVIR. 2020.

To study the efficacy of the JETi™ Peripheral Thrombectomy System in treating acute venous thrombosis.

Retrospective review of 40 total procedures in 30 patients with acute lower extremity venous thrombosis (25 iliocaval, 20 iliofemoral and 15 femoropopliteal segments).

Primary Endpoints
Technical Success Rate defined as reestablishment of inline flow.

Additional Endpoints
Percent thrombus removal, total thrombolytic dose, total procedural time, overnight thrombolysis post procedure, ICU length of stay, total hospital length of stay, procedure related complications, mean symptom duration and venous segments treated.

Clinical Outcomes

JETi™ Peripheral Thrombectomy System achieved a 93% overall technical success rate with 77% of patients successfully treated in a single-session. Patients treated with JETi™ in a single-session required less TPA and shorter ICU stays compared to those treated with overnight CDT. 


 Single-Session JETi™ Thrombectomy
(n = 23/30)
Overall JETi™ Thrombectomy*
(n = 30/30)
Mean ICU Length of Stay1.1 days1.6 days
Mean TPA Dose3.1 mg7.8 mg
Mean Thrombus Removal81.2%74.0%


*Data includes 7 patients requiring overnight CDT.

Restoration of inline flow was successfully achieved in 77% of patients in a single session.

JETI Restoration of Inline Flow

Single-session restoration of flow was associated with shorter ICU stays and a 60% lower dose of TPA when compared with overnight CDT.

JETi Shorter ICU Stays and Lower TPA Data

Technical success was achieved in 93% of patients treated with the JETi™ Thrombectomy System.

JETi Technical Success Data for Lower Extremity Venous Thrombosis


Khalsa et al., JVIR. 2020.

MAT-2209358 v1.0